Krumina E, Ocanto A, Couñago F. Vitamin D and prostate cancer prevention. World J Clin Oncol 2024; 15(6): 691-694 [PMID: 38946829 DOI: 10.5306/wjco.v15.i6.691]
Corresponding Author of This Article
Abrahams Ocanto, MD, Department of Radiation Oncology, San Francisco de Asís University Hospital, Genesis Care Madrid, Madrid 28002, Spain. abraham.ocanto@gmail.com
Research Domain of This Article
Oncology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Oncol. Jun 24, 2024; 15(6): 691-694 Published online Jun 24, 2024. doi: 10.5306/wjco.v15.i6.691
Vitamin D and prostate cancer prevention
Evita Krumina, Abrahams Ocanto, Felipe Couñago
Evita Krumina, Department of Radiation Oncology, GenesisCare Guadalajara, Guadalajara 19004, Spain
Abrahams Ocanto, Felipe Couñago, Department of Radiation Oncology, San Francisco de Asís University Hospital, GenesisCare Madrid, Madrid 28002, Spain
Abrahams Ocanto, Felipe Couñago, Department of Radiation Oncology, Vithas La Milagrosa University Hospital, GenesisCare Madrid, Madrid 28010, Spain
Felipe Couñago, National Director GenesisCare, Spain
Author contributions: Krumina E, Ocanto A and Couñago F designed the overall concept and outline of the manuscript; Krumina E contributed to the discussion and design of the manuscript; Krumina E, Ocanto A and Couñago F contributed to the writing, and editing the manuscript and review of literature.
Conflict-of-interest statement: The authors declare no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Abrahams Ocanto, MD, Department of Radiation Oncology, San Francisco de Asís University Hospital, Genesis Care Madrid, Madrid 28002, Spain. abraham.ocanto@gmail.com
Received: February 13, 2024 Revised: April 8, 2024 Accepted: May 6, 2024 Published online: June 24, 2024 Processing time: 131 Days and 11.1 Hours
Abstract
Vitamin D is a hot topic nowadays, especially its relationship with cancer prevention. Normally, vitamin D is associated with bone health principally, but the new research has discovered an impact on immune function and cellular signaling, even in same studies talk about a hormone, however, the most important relationship is its implication in cellular processes, inhibiting cancer growth. For now, the recent studies are oriented about a benefit and a cause-effect relationship between prostate cancer and normal levels of vitamin D. This premise opens a lot of questions in this scenario. This editorial highlighted the most important studies in this area.
Core Tip: This editorial remarks the importance of vitamin D beyond bone health and its relationship with prevention prostate cancer in the light of recent studies what suggests how deficiency and increased levels are related with an augmented risk of prostate cancer.
